APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bicalutamide Tablets Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchBicalutamide Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicalutamide Tablets Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Bicalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicalutamide Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicalutamide Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bicalutamide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bicalutamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bicalutamide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bicalutamide Tablets market include HISUN, Fosun Pharma, FORWARD, AstraZeneca and CordenPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bicalutamide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bicalutamide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bicalutamide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bicalutamide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Bicalutamide Tablets Segment by Company

HISUN

Fosun Pharma

FORWARD

AstraZeneca

CordenPharma

Bicalutamide Tablets Segment by Type

14 Tablets Per Box

28 Tablets Per Box

Bicalutamide Tablets Segment by Application

Hospital

Clinic

Bicalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bicalutamide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bicalutamide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bicalutamide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Bicalutamide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bicalutamide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bicalutamide Tablets industry.

Chapter 3: Detailed analysis of Bicalutamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bicalutamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bicalutamide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bicalutamide Tablets Industry Trends Table 2. Bicalutamide Tablets Industry Drivers Table 3. Bicalutamide Tablets Industry Opportunities and Challenges Table 4. Bicalutamide Tablets Industry Restraints Table 5. Global Bicalutamide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bicalutamide Tablets Revenue Share by Company (2021-2026) Table 7. Global Bicalutamide Tablets Sales Volume by Company (k units) & (2021-2026) Table 8. Global Bicalutamide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Bicalutamide Tablets Average Price (US$/unit) of Company (2021-2026) Table 10. Global Bicalutamide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bicalutamide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Bicalutamide Tablets Company, Product Type & Application Table 13. Global Bicalutamide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bicalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 14 Tablets Per Box Table 18. Significant Companies of 28 Tablets Per Box Table 19. Global Bicalutamide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Bicalutamide Tablets Sales Volume by Type (2021-2026) & (k units) Table 21. Global Bicalutamide Tablets Sales Volume by Type (2027-2032) & (k units) Table 22. Global Bicalutamide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Bicalutamide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Bicalutamide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bicalutamide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bicalutamide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bicalutamide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Bicalutamide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Bicalutamide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Bicalutamide Tablets Sales Volume by Application (2021-2026) & (k units) Table 33. Global Bicalutamide Tablets Sales Volume by Application (2027-2032) & (k units) Table 34. Global Bicalutamide Tablets Sales Volume Share by Application (2021-2026) Table 35. Global Bicalutamide Tablets Sales Volume Share by Application (2027-2032) Table 36. Global Bicalutamide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Bicalutamide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Bicalutamide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Bicalutamide Tablets Sales Value Share by Application (2021-2026) Table 40. Global Bicalutamide Tablets Sales Value Share by Application (2027-2032) Table 41. Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Bicalutamide Tablets Sales by Region (2021-2026) & (k units) Table 43. Global Bicalutamide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Bicalutamide Tablets Sales by Region (2027-2032) & (k units) Table 45. Global Bicalutamide Tablets Sales Market Share by Region (2027-2032) Table 46. Global Bicalutamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Bicalutamide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Bicalutamide Tablets Sales Value Share by Region (2021-2026) Table 49. Global Bicalutamide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Bicalutamide Tablets Sales Value Share by Region (2027-2032) Table 51. Global Bicalutamide Tablets Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Bicalutamide Tablets Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Bicalutamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Bicalutamide Tablets Sales by Country (2021-2026) & (k units) Table 56. Global Bicalutamide Tablets Sales Market Share by Country (2021-2026) Table 57. Global Bicalutamide Tablets Sales by Country (2027-2032) & (k units) Table 58. Global Bicalutamide Tablets Sales Market Share by Country (2027-2032) Table 59. Global Bicalutamide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Bicalutamide Tablets Sales Value Market Share by Country (2021-2026) Table 61. Global Bicalutamide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Bicalutamide Tablets Sales Value Market Share by Country (2027-2032) Table 63. HISUN Company Information Table 64. HISUN Business Overview Table 65. HISUN Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. HISUN Bicalutamide Tablets Product Portfolio Table 67. HISUN Recent Development Table 68. Fosun Pharma Company Information Table 69. Fosun Pharma Business Overview Table 70. Fosun Pharma Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Fosun Pharma Bicalutamide Tablets Product Portfolio Table 72. Fosun Pharma Recent Development Table 73. FORWARD Company Information Table 74. FORWARD Business Overview Table 75. FORWARD Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. FORWARD Bicalutamide Tablets Product Portfolio Table 77. FORWARD Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. AstraZeneca Bicalutamide Tablets Product Portfolio Table 82. AstraZeneca Recent Development Table 83. CordenPharma Company Information Table 84. CordenPharma Business Overview Table 85. CordenPharma Bicalutamide Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CordenPharma Bicalutamide Tablets Product Portfolio Table 87. CordenPharma Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Bicalutamide Tablets Distributors List Table 91. Bicalutamide Tablets Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Bicalutamide Tablets Product Image Figure 2. Global Bicalutamide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bicalutamide Tablets Sales (2021-2032) & (k units) Figure 5. Global Bicalutamide Tablets Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Bicalutamide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 14 Tablets Per Box Image Figure 10. 28 Tablets Per Box Image Figure 11. Global Bicalutamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Bicalutamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bicalutamide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Bicalutamide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bicalutamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bicalutamide Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Bicalutamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Bicalutamide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Bicalutamide Tablets Sales Volume Share by Application (2021-2032) Figure 22. Global Bicalutamide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Bicalutamide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Bicalutamide Tablets Sales Value Share by Application (2021-2032) Figure 25. Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Bicalutamide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Bicalutamide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Bicalutamide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. North America Bicalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Bicalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Bicalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. South America Bicalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Bicalutamide Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Bicalutamide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Bicalutamide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Bicalutamide Tablets Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Bicalutamide Tablets Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 14 Tablets Per Box
  • 28 Tablets Per Box
Applications
  • Hospital
  • Clinic
Companies covered
  • HISUN
  • Fosun Pharma
  • FORWARD
  • AstraZeneca
  • CordenPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bicalutamide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Bicalutamide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Bicalutamide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bicalutamide Tablets Market Dynamics
  1. 2.1 Bicalutamide Tablets Industry Trends
  2. 2.2 Bicalutamide Tablets Industry Drivers
  3. 2.3 Bicalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Bicalutamide Tablets Industry Restraints
3 Bicalutamide Tablets Market by Company
  1. 3.1 Global Bicalutamide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Bicalutamide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Bicalutamide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Bicalutamide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Bicalutamide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Bicalutamide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Bicalutamide Tablets Company Product Type and Application
  8. 3.8 Global Bicalutamide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bicalutamide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bicalutamide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bicalutamide Tablets Market by Type
  1. 4.1 Bicalutamide Tablets Type Introduction
  2. 4.1.1 14 Tablets Per Box
  3. 4.1.2 28 Tablets Per Box
  4. 4.2 Global Bicalutamide Tablets Sales Volume by Type
  5. 4.2.1 Global Bicalutamide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bicalutamide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bicalutamide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bicalutamide Tablets Sales Value by Type
  9. 4.3.1 Global Bicalutamide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bicalutamide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bicalutamide Tablets Sales Value Share by Type (2021-2032)
5 Bicalutamide Tablets Market by Application
  1. 5.1 Bicalutamide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bicalutamide Tablets Sales Volume by Application
  5. 5.2.1 Global Bicalutamide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bicalutamide Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Bicalutamide Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Bicalutamide Tablets Sales Value by Application
  9. 5.3.1 Global Bicalutamide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bicalutamide Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Bicalutamide Tablets Sales Value Share by Application (2021-2032)
6 Bicalutamide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Bicalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bicalutamide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Bicalutamide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Bicalutamide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Bicalutamide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bicalutamide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bicalutamide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bicalutamide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Bicalutamide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bicalutamide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Bicalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bicalutamide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Bicalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bicalutamide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bicalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bicalutamide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Bicalutamide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bicalutamide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bicalutamide Tablets Sales Value Share by Country, 2025 VS 2032
7 Bicalutamide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Bicalutamide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bicalutamide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bicalutamide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Bicalutamide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Bicalutamide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Bicalutamide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bicalutamide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bicalutamide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bicalutamide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bicalutamide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bicalutamide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 HISUN
  2. 8.1.1 HISUN Company Information
  3. 8.1.2 HISUN Business Overview
  4. 8.1.3 HISUN Bicalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 HISUN Bicalutamide Tablets Product Portfolio
  6. 8.1.5 HISUN Recent Developments
  7. 8.2 Fosun Pharma
  8. 8.2.1 Fosun Pharma Company Information
  9. 8.2.2 Fosun Pharma Business Overview
  10. 8.2.3 Fosun Pharma Bicalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fosun Pharma Bicalutamide Tablets Product Portfolio
  12. 8.2.5 Fosun Pharma Recent Developments
  13. 8.3 FORWARD
  14. 8.3.1 FORWARD Company Information
  15. 8.3.2 FORWARD Business Overview
  16. 8.3.3 FORWARD Bicalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 FORWARD Bicalutamide Tablets Product Portfolio
  18. 8.3.5 FORWARD Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Bicalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Bicalutamide Tablets Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 CordenPharma
  26. 8.5.1 CordenPharma Company Information
  27. 8.5.2 CordenPharma Business Overview
  28. 8.5.3 CordenPharma Bicalutamide Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CordenPharma Bicalutamide Tablets Product Portfolio
  30. 8.5.5 CordenPharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bicalutamide Tablets Value Chain Analysis
  2. 9.1.1 Bicalutamide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bicalutamide Tablets Sales Mode & Process
  6. 9.2 Bicalutamide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bicalutamide Tablets Distributors
  9. 9.2.3 Bicalutamide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst